Drug reduction reaction kettle
By introducing structures such as a base, annular frame, groove, limiting ring, and locking assembly into the drug reduction reactor, the problem of difficult disassembly of the stirring rod is solved, enabling rapid disassembly and cleaning of the reactor body and improving cleaning efficiency.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-03
- Publication Date
- 2026-04-07
AI Technical Summary
The stirring rod of the existing drug reduction reactor is difficult to remove from the inside of the reactor after use, resulting in low cleaning efficiency and affecting the cleaning effect of some areas inside the reactor.
A drug reduction reactor was designed. Through the cooperation of a base, annular frame, groove, limiting ring, locking assembly and drive assembly, the stirring rod can be quickly separated and the reactor body can be easily disassembled. The structure of slider, groove and spring simplifies the cleaning process of the reactor body.
It improves the convenience and cleaning efficiency of the drug reduction reactor, simplifies the disassembly and cleaning process of the reactor body, and enhances the overall ease of operation.
Smart Images

Figure CN224086718U_ABST
Abstract
Description
Technical Field
[0001] This utility model belongs to the field of pharmaceutical processing technology, and more specifically, it relates to a pharmaceutical reduction reaction vessel. Background Technology
[0002] A pharmaceutical reaction vessel is a container mainly used for chemical or physical reactions of various pharmaceutical raw materials. To accelerate the efficiency of drug preparation, the drugs are usually heated by introducing hot water steam into the reaction vessel to speed up the reaction rate, thereby improving the efficiency of drug production.
[0003] In some current drug reduction reactors, the stirring rod used to improve reaction efficiency is located inside the reactor. When the operator needs to clean the reactor after use, the stirring rod will obstruct the cleaning process, affecting the cleaning efficiency and making it difficult to thoroughly clean certain areas inside the reactor.
[0004] Therefore, in view of this, we have studied and improved the existing structure and its shortcomings, and provided a drug reduction reaction vessel in order to achieve a more practical purpose. Utility Model Content
[0005] To solve the above-mentioned technical problems, this utility model provides a drug reduction reaction vessel, which is achieved by the following specific technical means:
[0006] A drug reduction reaction vessel includes a base, an annular frame mounted on the top of the base via a bracket, a plurality of circumferentially spaced grooves on the inner side of the annular frame, a reaction vessel body placed inside the annular frame, a limiting ring mounted on the top of the reaction vessel body with dimensions matching those of the annular frame, a sealing groove on the top of the limiting ring, a locking assembly mounted on the surface of the reaction vessel body, a vertical plate mounted on one side of the base, a first sliding groove on one side of the vertical plate, a first slider slidably mounted in the first sliding groove, a cover plate assembly mounted on one side of the first slider, and a driving assembly mounted in the first sliding groove.
[0007] Furthermore, the engaging assembly includes a plurality of second sliding grooves, which are circumferentially and equidistantly arranged on the periphery of the reactor vessel. The positions of the second sliding grooves match the positions of the grooves. A second slider is slidably mounted in the second sliding groove, and one end of the second slider extends to the outside of the second sliding groove. The second slider has a protrusion at the end located outside the second sliding groove, and the size of the protrusion at the end of the second slider matches the size of the groove. A compression spring is mounted at the end of the second slider located inside the second sliding groove, and the other end of the compression spring is connected to one side of the second sliding groove.
[0008] Furthermore, the cover assembly includes a connecting block, which is bolted to one side of the first slider. A reactor compartment cover is installed on one side of the connecting block. The reactor compartment cover is located directly above the reactor tank, and the size of the reactor compartment cover matches the size of the reactor tank. A stirring rod is rotatably installed on the bottom inner side of the reactor compartment cover. A first motor is installed on the top of the connecting block via a bracket, and the output end of the first motor is connected to the stirring rod via a coupling.
[0009] Furthermore, a sealing ring is installed at the bottom of the reactor chamber cover, and the position and size of the sealing ring match the position and size of the sealing groove.
[0010] Furthermore, the drive assembly includes a threaded rod, which is rotatably mounted in the first slide groove and passes through the upper and lower ends of the first slider and is threadedly connected to the first slider.
[0011] Furthermore, a second motor is installed at the top of the upright plate, and the output end of the second motor is connected to the threaded rod via a coupling.
[0012] Furthermore, a controller is mounted on the top of the base.
[0013] Compared with the prior art, the present invention has the following beneficial effects:
[0014] The drug reduction reactor of this utility model, through the coordinated use of a base, annular frame, groove, reactor body, limiting ring, sealing groove, upright plate, first sliding groove, first slider, second sliding groove, second slider, compression spring, connecting block, reactor cover, stirring rod, first motor, sealing ring, threaded rod, second motor and controller, facilitates the quick separation of the stirring rod from the reactor body by raising and lowering the reactor cover, and the quick removal and cleaning of the reactor body by the cooperation of the groove and locking assembly, thereby improving the convenience of the drug reduction reactor and the efficiency of disassembling and cleaning the drug reduction reactor. Attached Figure Description
[0015] Figure 1 This is a three-dimensional schematic diagram of the present invention.
[0016] Figure 2 This is a three-dimensional schematic diagram of the reaction vessel of this utility model.
[0017] Figure 3 This is a side sectional view of the present invention.
[0018] Figure 4 This is the utility model Figure 3 An enlarged schematic diagram of part A in the middle.
[0019] In the diagram, the correspondence between component names and drawing numbers is as follows:
[0020] 1. Base; 2. Ring frame; 3. Groove; 4. Reactor body; 5. Limiting ring; 6. Sealing groove; 7. Vertical plate; 8. First slide groove; 9. First slider; 10. Second slide groove; 11. Second slider; 12. Compression spring; 13. Connecting block; 14. Reactor cover; 15. Stirring rod; 16. First motor; 17. Sealing ring; 18. Threaded rod; 19. Second motor; 20. Controller. Detailed Implementation
[0021] The embodiments of this utility model will be described in further detail below with reference to the accompanying drawings and examples. The following examples are for illustrative purposes only and should not be construed as limiting the scope of this utility model.
[0022] In the description of this utility model, unless otherwise stated, "a plurality of" means two or more; the terms "upper," "lower," "left," "right," "inner," "outer," "front end," "rear end," "head," "tail," etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this utility model. In addition, the terms "first," "second," "third," etc., are used for descriptive purposes only and should not be construed as indicating or implying relative importance.
[0023] In the description of this utility model, it should be noted that, unless otherwise explicitly specified and limited, the terms "connected" and "linked" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium. Those skilled in the art can understand the specific meaning of the above terms in this utility model based on the specific circumstances.
[0024] Example:
[0025] As attached Figure 1 To be continued Figure 4 As shown:
[0026] This utility model provides a drug reduction reaction vessel, including a base 1, an annular frame 2 mounted on the top of the base 1 via a bracket, a plurality of grooves 3 evenly spaced around the inner side of the annular frame 2, a reaction vessel body 4 placed inside the annular frame 2, a limiting ring 5 mounted on the top of the reaction vessel body 4, the size of the limiting ring 5 matching the size of the annular frame 2, a sealing groove 6 at the top of the limiting ring 5, a locking assembly mounted on the surface of the reaction vessel body 4, a vertical plate 7 mounted on one side of the base 1, a first sliding groove 8 on one side of the vertical plate 7, a first slider 9 slidably mounted in the first sliding groove 8, a cover plate assembly mounted on one side of the first slider 9, and a driving assembly mounted in the first sliding groove 8.
[0027] The locking assembly includes several second sliding grooves 10, which are circumferentially and equidistantly arranged on the periphery of the reactor vessel 4. The positions of the second sliding grooves 10 match the positions of several grooves 3. A second slider 11 is slidably installed in the second sliding groove 10, and one end of the second slider 11 extends to the outside of the second sliding groove 10. The second slider 11 has a protrusion at the end located outside the second sliding groove 10, and the size of the protrusion at one end of the second slider 11 matches the size of the groove 3. A compression spring 12 is installed at the end of the second slider 11 located inside the second sliding groove 10, and the other end of the compression spring 12 is connected to one side of the second sliding groove 10. The reactor vessel 4 is fixed by locking the protrusion on one side of the second slider 11 with the groove 3. When it is necessary to disassemble the reactor vessel 4, the operator rotates the reactor vessel 4 to disengage the second slider 11 from the groove 3 and remove it from the reactor vessel 4. Then, the reactor vessel 4 can be removed by pushing it upward.
[0028] The cover assembly includes a connecting block 13, which is bolted to one side of the first slider 9. A reaction vessel cover 14 is installed on one side of the connecting block 13. The reaction vessel cover 14 is located directly above the reaction vessel tank 4, and the size of the reaction vessel cover 14 matches the size of the reaction vessel tank 4. A stirring rod 15 is rotatably installed on the bottom of the inner side of the reaction vessel cover 14. A first motor 16 is installed on the top of the connecting block 13 through a bracket, and the output end of the first motor 16 is connected to the stirring rod 15 through a coupling. The first motor 16 drives the stirring rod 15 to rotate, which facilitates the stirring and mixing of the drugs in the reaction vessel tank 4.
[0029] The bottom of the reactor cover 14 is equipped with a sealing ring 17, and the position and size of the sealing ring 17 match the position and size of the sealing groove 6. By inserting the sealing ring 17 into the sealing groove 6, the sealing performance of the reactor cover 14 and the reactor tank 4 is improved.
[0030] The drive assembly includes a threaded rod 18, which is rotatably installed in the first slide groove 8 and passes through the upper and lower ends of the first slider 9 and is threadedly connected to the first slider 9. Through the rotation of the threaded rod 18, the first slider 9 moves under the limiting action of the first slide groove 8 and drives the reactor cover 14 to move through the connecting block 13.
[0031] The top of the vertical plate 7 is equipped with a second motor 19, and the output end of the second motor 19 is connected to the threaded rod 18 through a coupling. The second motor 19 drives the threaded rod 18 to rotate, thereby driving the first slider 9 to move.
[0032] The base 1 has a controller 20 installed at its top. The controller 20 is electrically connected to the first motor 16 and the second motor 19, which facilitates the control of the overall circuit of the device.
[0033] The working principle of this embodiment is as follows: When using the drug reduction reactor, the operator first puts the drug raw material into the reactor tank 4, then turns on the second motor 19. The second motor 19 drives the threaded rod 18 to rotate. Under the limiting action of the first sliding groove 8, the first slider 9 moves and drives the reactor cover 14 downward through the connecting block 13, so that the reactor cover 14 is connected to the reactor tank 4. At this time, the sealing ring 17 enters the sealing groove 6, improving the sealing performance of the drug reduction reactor. Then, the operator turns on the first motor 16, which drives the stirring rod 15 to rotate, increasing the drug reaction rate inside the reactor tank 4. When the operator removes the drug and needs to clean the reactor tank 4 and the stirring rod 15, the operator can first turn on the second motor 19, causing the connecting block 13 to move downward. The reaction vessel cover 14 is moved upward, causing the stirring rod 15 to disengage from the inside of the reaction vessel tank 4. At this time, the operator can remove the bolts on one side of the connecting block 13 to disassemble the reaction vessel cover 14. Then, the operator rotates the reaction vessel tank 4 to disengage the second slider 11 from the groove 3 and no longer limit the reaction vessel tank 4. Finally, the reaction vessel tank 4 is pushed upward to remove it for easy cleaning. When reinstalling the reaction vessel tank 4, the operator reinserts the reaction vessel tank 4 into the annular frame 2, so that the bottom end of the limiting ring 5 contacts the top end of the annular frame 2. Then, the operator rotates the reaction vessel tank 4 to move the second slider 11 to a position parallel to the groove 3. At this time, under the action of the compression spring 12, the second slider 11 is inserted into the groove 3 and fixes the reaction vessel tank 4.
[0034] The embodiments of this utility model are given for illustrative and descriptive purposes only, and are not intended to be exhaustive or to limit the utility model to the forms disclosed. Many modifications and variations will be apparent to those skilled in the art. The embodiments were chosen and described in order to better illustrate the principles and practical applications of this utility model, and to enable those skilled in the art to understand this utility model and design various embodiments with various modifications suitable for a particular purpose.
Claims
1. A drug reduction reactor, comprising a base (1), characterized in that: The top of the base (1) is fitted with a ring frame (2) via a bracket. The inner side of the ring frame (2) is provided with several grooves (3) at equal intervals around the circumference. The inner side of the ring frame (2) is placed with a reactor tank (4). The top of the reactor tank (4) is fitted with a limiting ring (5), and the size of the limiting ring (5) matches the size of the ring frame (2). The top of the limiting ring (5) is provided with a sealing groove (6). The surface of the reactor tank (4) is fitted with a locking assembly. A vertical plate (7) is fitted on one side of the base (1). A first sliding groove (8) is provided on one side of the vertical plate (7). A first slider (9) is slidably installed in the first sliding groove (8). A cover plate assembly is installed on one side of the first slider (9). A driving assembly is installed in the first sliding groove (8).
2. The drug reduction reactor as described in claim 1, characterized in that: The engaging assembly includes a plurality of second sliding grooves (10), which are circumferentially and equidistantly arranged on the periphery of the reactor body (4). The positions of the plurality of second sliding grooves (10) match the positions of the plurality of grooves (3). A second slider (11) is slidably installed in the second sliding groove (10), and one end of the second slider (11) extends to the outside of the second sliding groove (10). The second slider (11) has a protrusion at one end located outside the second sliding groove (10), and the size of the protrusion at one end of the second slider (11) matches the size of the groove (3). A compression spring (12) is installed at one end of the second slider (11) located inside the second sliding groove (10), and the other end of the compression spring (12) is connected to one side of the second sliding groove (10).
3. The drug reduction reactor as described in claim 1, characterized in that: The cover assembly includes a connecting block (13), which is bolted to one side of the first slider (9). A reactor cover (14) is installed on one side of the connecting block (13). The reactor cover (14) is located directly above the reactor tank (4), and the size of the reactor cover (14) matches the size of the reactor tank (4). A stirring rod (15) is rotatably installed on the bottom of the inner side of the reactor cover (14). A first motor (16) is installed on the top of the connecting block (13) through a bracket, and the output end of the first motor (16) is connected to the stirring rod (15) through a coupling.
4. The drug reduction reactor as described in claim 3, characterized in that: A sealing ring (17) is installed at the bottom of the reactor chamber cover (14), and the position and size of the sealing ring (17) match the position and size of the sealing groove (6).
5. The drug reduction reactor as described in claim 1, characterized in that: The drive assembly includes a threaded rod (18), which is rotatably mounted in the first slide groove (8) and passes through the upper and lower ends of the first slider (9) and is threadedly connected to the first slider (9).
6. The drug reduction reactor as described in claim 5, characterized in that: The top of the upright plate (7) is equipped with a second motor (19), and the output end of the second motor (19) is connected to the threaded rod (18) via a coupling.
7. The drug reduction reactor as described in claim 1, characterized in that: A controller (20) is mounted on the top of the base (1).